Skip links

Ingrezza® (valbenazine)

Full Name Ingrezza® (valbenazine)
Drug Ingrezza
Manufacturer Neurocrine Biosciences
Route of Administration Oral
Site of Care Home
Approved Indication The treatment of adults with tardive dyskinesia or chorea associated with Huntington’s disease
Disease Tardive Dyskinesia (TD); Huntington’s Disease Chorea
Therapeutic Area Psychiatry, Neurology
Enrollment Form Link Enrollment Form
Phone Number 800-279-1676
Fax Number 877-868-1681
Product Website